Human Chorionic Gonadotropin (hCG) Research for Male Hypogonadism
An evidence-based overview of research examining Human Chorionic Gonadotropin (hCG) in the context of male hypogonadism. This page synthesizes findings from peer-reviewed literature.
Research Summary
hCG is FDA-approved for hypogonadotropic hypogonadism and is commonly used to maintain fertility during testosterone replacement therapy. Clinical studies demonstrate preservation of intratesticular testosterone and spermatogenesis with concurrent hCG administration.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Male Hypogonadism
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Human Chorionic Gonadotropin (hCG) may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.